Syddansk Universitet

Medicin og biovidenskab

1. Denmark 100%
2. Cohort Studies 54%
3. Population 45%
4. Randomized Controlled Trials 42%
5. Systematic Reviews 40%
6. Child 39%
7. Therapeutics 39%
8. Mortality 38%
9. Exercise 36%
10. Health 32%
11. Neoplasms 30%
12. Confidence Intervals 30%
13. Registries 26%
14. Meta-Analysis 25%
15. Pain 24%
16. Genes 24%
17. Proteins 23%
18. Type 2 Diabetes Mellitus 22%
19. Cross-Sectional Studies 21%
20. Delivery of Health Care 20%
21. Low Back Pain 20%
22. Survival 20%
23. Quality of Life 20%
24. Twins 19%
25. Incidence 19%
26. Prospective Studies 19%
27. Mutation 19%
28. Breast Neoplasms 17%
29. Guidelines 17%
30. Biomarkers 17%
31. Odds Ratio 17%
32. Pregnancy 17%
33. Parturition 17%
34. Pharmaceutical Preparations 16%
35. Placebos 15%
36. Depression 15%
37. Databases 15%
38. Myocardial Infarction 14%
39. Interviews 14%
40. Serum 14%
41. Glucose 14%
42. Muscles 14%
43. Mothers 14%
44. Colorectal Neoplasms 13%
45. Bone and Bones 13%
46. Rheumatoid Arthritis 13%
47. Knee Osteoarthritis 13%
48. Education 13%
49. Phenotype 12%
50. Cardiovascular Diseases 12%
51. Wounds and Injuries 12%
52. Alcohols 12%
53. Body Mass Index 12%
54. Proteomics 12%
55. Observational Studies 12%
56. Guinea-Bissau 12%
57. Occupational Groups 12%
58. Infections 12%
59. Kidney 12%
60. Patient Reported Outcome Measures 12%
61. Blood Pressure 12%
62. Hip 11%
63. Asthma 11%
64. Smoking 11%
65. Chronic Obstructive Pulmonary Disease 11%
66. Obesity 11%
67. Rehabilitation 11%
68. Greenland 11%
69. Safety 11%
70. Multiple Sclerosis 11%
71. Knee 11%
72. Hypersensitivity 10%
73. Lipids 10%
74. Type 1 Diabetes Mellitus 10%
75. Atrial Fibrillation 10%
76. Elderly 10%
77. HIV 10%
78. Recurrence 10%
79. Comorbidity 10%
80. Insulin 10%
81. Costs and Cost Analysis 10%
82. Stroke 10%
83. General Practitioners 10%
84. Mass Spectrometry 10%
85. Brain 10%
86. Life Style 10%
87. Inflammation 10%
88. Multicenter Studies 9%
89. Heart Failure 9%
90. Twin Studies 9%
91. General Practice 9%
92. Case-Control Studies 9%
93. Mental Health 9%
94. Referral and Consultation 9%
95. Longevity 9%
96. Lung 9%
97. Equipment and Supplies 9%
98. Morbidity 9%
99. Drug Therapy 9%
100. Vaccination 9%